High‐throughput proteomics uncovers molecular clusters and biomarkers of severity in bullous pemphigoid

CCL13 was among the most prominent inflammatory proteins identified in bullous pemphigoid. The emergence of two distinct skin proteomic clusters highlights a biological heterogeneity of bullous pemphigoid, indicating the need for endotype-driven, personalized treatment strategies.